ArticleDNA repair2025
MCM8/9 and FANCD2 interact within a shared pathway in response to replication stress caused by DNA crosslinks.
Article in DNA repair, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Structural Activation of DNA Unwinding by MCM8/9/HROB.bioRxiv : the preprint server for biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The Fanconi anemia (FA) protein FANCD2, and MCM8/9 heterohexameric helicase complex are critical for maintaining genomic integrity in response to replication stress, however, the nature of their relationship remains unclear. Here, we show that MCM8/9 interacts and functionally cooperates with FANCD2 within a complex during the repair of DNA interstrand crosslinks (ICLs). Using immunofluorescence and co-immunoprecipitation studies, we show that MCM8/9 interacts with the FANCD2 complex through its core domain. FANCD2 is essential for the recruitment of MCM8/9 to ICL damage induced nuclear foci but acts independently of FANCD2 monoubiquitination. Although MCM8/9 foci formation requires its intact ATPase activity, the BRCv motif within the MCM9 C-terminal extension (CTE) and the accessory protein, HROB, these are not required for FANCD2 binding, highlighting a distinction between physical interaction and functional activation. Interestingly, FANCD2 foci formation increases in MCM8 or MCM9 knockout cells or with knockdown of the activator, HROB, suggesting that MCM8/9 functions to mitigate replication-associated stress. γH2AX DNA damage assays and cell survival assays show that combined loss of MCM9 and FANCD2 do not cause additive DNA damage beyond individual knockouts, indicating an epistatic relationship of MCM8/9 with FANCD2, functioning in the same DNA repair pathway. Together, our findings identify MCM8/9 as a downstream interactor and effector of FANCD2/I critical for resolving ICL induced DNA damage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.